Literature DB >> 22907583

Intermittent detection of fetal heart rate abnormalities identify infants at greatest risk for fresh stillbirths, birth asphyxia, neonatal resuscitation, and early neonatal deaths in a limited-resource setting: a prospective descriptive observational study at Haydom Lutheran Hospital.

Hege Langli Ersdal1, Estomih Mduma, Erling Svensen, Johanne Sundby, Jeffrey Perlman.   

Abstract

BACKGROUND: Intermittent fetal heart rate (FHR) monitoring during labor using an acoustic stethoscope is the most frequent method for fetal assessment of well-being in low- and middle-income countries. Evidence concerning reliability and efficacy of this technique is almost nonexistent.
OBJECTIVES: To determine the value of routine intermittent FHR monitoring during labor in the detection of FHR abnormalities, and the relationship of abnormalities to the subsequent fresh stillbirths (FSB), birth asphyxia (BA), need for neonatal face mask ventilation (FMV), and neonatal deaths within 24 h.
METHODS: This is a descriptive observational study in a delivery room from November 2009 through December 2011. Research assistants/observers (n = 14) prospectively observed every delivery and recorded labor information including FHR and interventions, neonatal information including responses in the delivery room, and fetal/neonatal outcomes (FSB, death within 24 h, admission neonatal area, or normal).
RESULTS: 10,271 infants were born. FHR was abnormal (i.e. <120 or >160 beats/min) in 279 fetuses (2.7%) and absent in 200 (1.9%). Postnatal outcomes included FSB in 159 (1.5%), need for FMV in 695 (6.8%), BA (i.e. 5-min Apgar score <7) in 69 (0.7%), and deaths in 89 (0.9%). Abnormal FHR was associated with labor complications (OR = 31.4; 95% CI: 23.1-42.8), increased need for FMV (OR = 7.8; 95% CI: 5.9-10.1), BA (OR = 21.7; 95% CI: 12.7-37.0), deaths (OR = 9.9; 95% CI: 5.6-17.5), and FSB (OR = 35; 95% CI: 20.3-60.4). An undetected FHR predicted FSB (OR = 1,983; 95% CI: 922-4,264).
CONCLUSIONS: Intermittent detection of an absent or abnormal FHR using a fetal stethoscope is associated with FSB, increased need for neonatal resuscitation, BA, and neonatal death in a limited-resource setting. The likelihood of an abnormal FHR is magnified with labor complications.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22907583     DOI: 10.1159/000339481

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  10 in total

1.  Stillbirths and neonatal mortality as outcomes.

Authors:  Robert L Goldenberg; Elizabeth M McClure; Alan H Jobe; Beena D Kamath-Rayne; Michael G Gravette; Craig E Rubens
Journal:  Int J Gynaecol Obstet       Date:  2013-09-04       Impact factor: 3.561

2.  Midwives' perceptions on using a fetoscope and Doppler for fetal heart rate assessments during labor: a qualitative study in rural Tanzania.

Authors:  Paschal Francis Mdoe; Hege Langli Ersdal; Estomih Mduma; Robert Moshiro; Hussein Kidanto; Columba Mbekenga
Journal:  BMC Pregnancy Childbirth       Date:  2018-04-16       Impact factor: 3.007

3.  Perceptions and experiences of skilled birth attendants on using a newly developed strap-on electronic fetal heart rate monitor in Tanzania.

Authors:  Sara Rivenes Lafontan; Hussein L Kidanto; Hege L Ersdal; Columba K Mbekenga; Johanne Sundby
Journal:  BMC Pregnancy Childbirth       Date:  2019-05-10       Impact factor: 3.007

4.  Frequent refresher training on newborn resuscitation and potential impact on perinatal outcome over time in a rural Tanzanian hospital: an observational study.

Authors:  Estomih Mduma; Jan Terje Kvaløy; Eldar Soreide; Erling Svensen; Paschal Mdoe; Jeffrey Perlman; Caroline Johnson; Hussein Lessio Kidanto; Hege Langli Ersdal
Journal:  BMJ Open       Date:  2019-09-27       Impact factor: 2.692

5.  Systematic review of Doppler for detecting intrapartum fetal heart abnormalities and measuring perinatal mortality in low- and middle-income countries.

Authors:  Marya Plotkin; Benjamin Kamala; Jim Ricca; Linda Fogarty; Sheena Currie; Hussein Kidanto; Stephanie B Wheeler
Journal:  Int J Gynaecol Obstet       Date:  2019-12-05       Impact factor: 3.561

6.  Evaluating time between birth to cry or bag and mask ventilation using mobile delivery room timers in India: the NICHD Global Network's Helping Babies Breathe Trial.

Authors:  Manjunath S Somannavar; Shivaprasad S Goudar; Amit P Revankar; Janet L Moore; Elizabeth M McClure; Pablo Destefanis; Martha DeCain; Norman Goco; Linda L Wright
Journal:  BMC Pediatr       Date:  2015-08-06       Impact factor: 2.125

7.  Intermittent fetal heart rate monitoring using a fetoscope or hand held Doppler in rural Tanzania: a randomized controlled trial.

Authors:  Paschal Francis Mdoe; Hege L Ersdal; Estomih R Mduma; Jeffrey M Perlman; Robert Moshiro; Peter T Wangwe; Hussein Kidanto
Journal:  BMC Pregnancy Childbirth       Date:  2018-05-04       Impact factor: 3.007

8.  Intrapartum fetal heart rate monitoring using a handheld Doppler versus Pinard stethoscope: a randomized controlled study in Dar es Salaam.

Authors:  Benjamin A Kamala; Hussen L Kidanto; Peter J Wangwe; Ingvild Dalen; Estomih R Mduma; Jeffrey M Perlman; Hege L Ersdal
Journal:  Int J Womens Health       Date:  2018-07-09

9.  Strategies for intrapartum foetal surveillance in low- and middle-income countries: A systematic review.

Authors:  Natasha Housseine; Marieke C Punt; Joyce L Browne; Tarek Meguid; Kerstin Klipstein-Grobusch; Barbara E Kwast; Arie Franx; Diederick E Grobbee; Marcus J Rijken
Journal:  PLoS One       Date:  2018-10-26       Impact factor: 3.240

10.  Scale-Up of Doppler to Improve Intrapartum Fetal Heart Rate Monitoring in Tanzania: A Qualitative Assessment of National and Regional/District Level Implementation Factors.

Authors:  Marya Plotkin; John George; Felix Bundala; Gaudiosa Tibaijuka; Lusekelo Njonge; Ruth Lemwayi; Mary Drake; Dunstan Bishanga; Barbara Rawlins; Rohit Ramaswamy; Kavita Singh; Stephanie Wheeler
Journal:  Int J Environ Res Public Health       Date:  2020-03-16       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.